C. auris is a type of fungus that can cause severe infections in humans, particularly those with weakened immune systems. The CDC has identified it as a mounting threat due to its ability to resist multiple antifungal drugs, making it difficult to treat. It has been found in healthcare settings such as hospitals and nursing homes, and can spread easily between patients. Therefore, early detection and strict infection control measures are essential to prevent its spread.
 |
| C. auris Fungus Is an 'Increasing Threat,' CDC Says |
Drug-Resistant Fungus Candida Auris Spreading Alarmingly in Healthcare Facilities
The US Centers for Disease Control and Prevention (CDC) has issued a warning about the rapid and alarming spread of the drug-resistant fungus Candida auris in medical facilities. While C. auris does not pose a significant threat to healthy individuals, it is a deadly threat to patients who are seriously ill or have extended hospital stays. The fungus is often resistant to multiple antifungal drugs and can spread easily in healthcare settings such as hospitals and nursing homes.
What is C. Auris?
Candida auris is a type of fungus or yeast that was first identified in 2009. It is considered an "emerging pathogen" due to its growth in countries outside of where it was first identified. The fungus can enter the bloodstream and cause severe or fatal infections in some patients. C. auris is mostly a threat to patients who have weakened immune systems, multiple medical problems, or have had extended hospital stays and have been treated with invasive medical devices.
~2.jpeg)
How does it spread?
Candida auris spreads in healthcare settings such as hospitals and nursing homes. It can cause outbreaks through direct contact or by touching contaminated surfaces. Patients who get sick with C. auris tend to already be ill for another reason, and symptoms may not always be noticeable and can depend on the part of the body that's infected. Lab tests are needed to diagnose an infection with C. auris.
Why is it a threat now?
The rapid and alarming spread of C. auris, coupled with cases that may be resistant to drugs typically used to treat it, make it an urgent threat. The CDC believes that increased efforts to detect cases may have contributed to the rise in case counts. Additionally, poor general infection prevention in healthcare facilities and the strain on healthcare and public health systems during the COVID-19 pandemic may have worsened the spread of the fungus.
Implications and Recommendations
The CDC is calling for continued surveillance, expanded lab capacity, quicker diagnostic tests, and adherence to proven infection prevention and control measures to curb the spread of C. auris. Healthcare workers are urged to be aware of the threat and take necessary precautions to prevent the spread of the fungus in healthcare settings. The public is advised to consult a physician or other qualified healthcare provider for any questions or concerns regarding medical conditions or health objectives.